Evaluation of the AID ESBL line probe assay for rapid detection of extended-spectrum β-lactamase (ESBL) and KPC carbapenemase genes in enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 1, 2014, Pages 85-90

  Bloemberg, Guido V ^a   Polsfuss, Silke ^a   Meyer, Vera ^a   Böttger, Erik C ^a   Hombach, Michael ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antibiotic resistance; Ctx M; Kpc; Shv; Tem

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE;

AMPLICON; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ASSAY; ESBL LINE PROBE ASSAY; ESCHERICHIA COLI; FALSE POSITIVE RESULT; GENE IDENTIFICATION; KLEBSIELLA PNEUMONIAE; KPC GENE; MEASUREMENT ACCURACY; NONHUMAN; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; RAPID TEST; SENSITIVITY AND SPECIFICITY; WILD TYPE;

ANTIBIOTIC RESISTANCE; CTX-M; KPC; SHV; TEM;

BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE PROBES; SENSITIVITY AND SPECIFICITY;

EID: 84890349814     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt345     Document Type: Article

References (20)

1. Bradford PA. Extended-spectrum b-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 4: 933-51.
2. Paterson DL, Bonomo RA. Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
3. Pitout JD. Infections with extended-spectrum b-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010; 70: 313-33.
4. Rodríguez-Baño J, Navarro MD, Romero L et al. Bacteremia due to extended-spectrum b-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006; 43: 1407-14.
5. Jacoby GA, Munoz-Price LS. The new b-lactamases. N Engl J Med 2005; 352: 380-91.
6. Pitout JD, Laupland KB. Extended-spectrum b-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
7. Jacoby GA. AmpC b-lactamases. Clin Microbiol Rev 2009; 22: 161-82.
8. Polsfuss S, Bloemberg G, Giger J et al. Evaluation of a diagnostic flow-chart fordetectionandconfirmationofextendedspectrumb-lactamases (ESBL) in Enterobacteriaceae. Clin Microbiol Infect 2012; 18: 1194-204.
9. Monstein HJ, Tärnberg M, Nilsson LE. Molecular identification of CTX-M and blaOXY/K1 b-lactamase genes in Enterobacteriaceae by sequencing of universal M13-sequence tagged PCR-amplicons. BMC Infect Dis 2009; 9: 7.
10. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum b-lactamases. Clin Infect Dis 2006; 42 Suppl 4: S153-63.
11. Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum b-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010; 23: 320-6.
12. Livermore DM, Canton R, GniadkowskiMet al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165-74.
13. MolandES, HansonND, BlackJAet al. Prevalence ofnewerb-lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 2006; 44: 3318-24.
14. Pitout JD, Hossain A, HansonND. Phenotypicandmolecular detection of CTX-M-b-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004; 42: 5715-21.
15. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum b-lactamases. J Antimicrob Chemother 2006; 57: 154-5.
16. Endimiani A, Hujer AM, Hujer KM et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type b-lactamase genes in Gram-negative isolates. J Clin Microbiol 2010; 48: 2618-22.
17. Naas T, Cuzon G, Truong H et al. Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum b-lactamases and KPC carbapenemases. Antimicrob Agents Chemother 2010; 54: 3086-92.
18. Cuzon G, Naas T, Bogaerts P et al. Evaluation of a DNAmicroarray for the rapid detection of extended-spectrumb-lactamases(TEM, SHVandCTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 2012; 67: 1865-9.
19. Ling DI, Zwerling AA, Pai M. Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. Expert Rev Respir Med 2008; 2: 583-8.
20. Otte KM, Jenner S, Wulffen HV. Identification of methicillin-resistant Staphylococcus aureus (MRSA): comparison of a new molecular genetic test kit (GenoType MRSA) with standard diagnostic methods. Clin Lab 2005; 51: 389-93.